Suppr超能文献

在两个tuf基因均发生改变的大肠杆菌突变体中对奇霉素具有抗性的延伸因子Tu

Elongation factor Tu resistant to kirromycin in an Escherichia coli mutant altered in both tuf genes.

作者信息

Fischer E, Wolf H, Hantke K, Parmeggiani A

出版信息

Proc Natl Acad Sci U S A. 1977 Oct;74(10):4341-5. doi: 10.1073/pnas.74.10.4341.

Abstract

A mutant of Escherichia coli is described that displays kirromycin resistance in a cell-free system by virtue of an altered elongation factor Tu (EF-Tu). In poly(U)-directed poly(Phe) synthesis the kirromycin resistance of the crystallized enzyme ranged between a factor of 80 and 700, depending on temperature. Similarly, kirromycin-induced EF-Tu GTPase activity uncoupled from ribosomes and aminoacyl-tRNA required correspondingly higher concentrations of the antibiotic. Resistance of EF-Tu to kirromycin is a consequence of a modified enzyme structure as indicated by its altered fingerprint pattern.P1 transduction experiments showed that the kirromycin-resistant EF-Tu is coded by an altered tufB gene (tufB1). The known existence of two genes coding for EF-Tu would interfere with the recognition of a mutant altered in only one of those genes, if the mutation were recessive. Because kirromycin blocks EF-Tu release from the ribosome, kirromycin sensitivity is dominant, as shown by the failure of a mixed EF-Tu population to express resistance in vitro. Therefore, phenotypic expression of kirromycin resistance in vivo appears to be only possible if the EF-Tu mutant lacks an active tufA gene, a property likely to be inherited from the parental D22 strain. The observations that introduction of a tufA(+) region makes the resistant strain sensitive to the antibiotic and that transduction of tufB1 into a recipient other than E. coli D22 yields kirromycin-sensitive progeny support these conclusions.

摘要

本文描述了一种大肠杆菌突变体,该突变体在无细胞系统中表现出对奇霉素的抗性,这是由于其延伸因子Tu(EF-Tu)发生了改变。在聚尿苷酸(poly(U))指导的多聚苯丙氨酸(poly(Phe))合成中,结晶酶对奇霉素的抗性在80至700倍之间,具体取决于温度。同样,从核糖体和氨酰-tRNA解偶联的奇霉素诱导的EF-Tu GTP酶活性相应地需要更高浓度的抗生素。EF-Tu对奇霉素的抗性是酶结构改变的结果,这一点通过其改变的指纹图谱得以表明。P1转导实验表明,抗奇霉素的EF-Tu由一个改变的tufB基因(tufB1)编码。如果该突变是隐性的,那么已知存在的两个编码EF-Tu的基因会干扰对仅其中一个基因发生改变的突变体的识别。由于奇霉素会阻止EF-Tu从核糖体释放,如混合的EF-Tu群体在体外无法表达抗性所示,奇霉素敏感性是显性的。因此,只有当EF-Tu突变体缺乏活性tufA基因时,体内才可能出现对奇霉素抗性的表型表达,这种特性可能是从亲本D22菌株遗传而来的。将tufA(+)区域导入抗性菌株会使其对该抗生素敏感,以及将tufB1转导到除大肠杆菌D22之外的受体中会产生对奇霉素敏感的后代,这些观察结果支持了这些结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b9/431937/8fc28674bea2/pnas00032-0240-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验